SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 ¦ÌM in biochemical kinase assays.

June 21, 2017

prudect name : SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 ¦ÌM in biochemical kinase assays.
SKLB 610;SKLB610

Synonyms: CAS NO: 1125780-41-7Molecular Formula: C₂₁H₁₆F₃N₃O₃Molecular Weight: 415.37Purity: 98% minSolubility: in DMSOStorage: -20oC

web site: www.medchemexpress.com